Icagen Financial Statements
Icagen Financial Information
| Company Type | Public Single Location |
|---|---|
| Fiscal Year-End | December |
| Investor Relations | Company Web Site |
This data is provided as per license from EDGAR Online
Icagen Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 21.1 | 8.4 | 8.8 |
| Gross Profit ($ mil.) | -- | -- | -- |
| Operating Income ($ mil.) | (12.7) | (26.3) | (21.7) |
| Total Net Income ($ mil.) | (10.9) | (24.8) | (20.3) |
| Diluted EPS (Net Income) | (0.29) | (1.12) | (1.03) |
Icagen Quarterly Statements
| Quarter Ending Jun 08 | Quarter Ending Mar 08 | Quarter Ending Dec 07 | |
|---|---|---|---|
| Revenue ($ mil.) | 3.2 | 3.0 | 2.9 |
| Gross Profit ($ mil.) | -- | -- | -- |
| Operating Income ($ mil.) | (4.0) | (4.0) | (4.1) |
| Total Net Income ($ mil.) | (3.7) | (3.6) | (3.6) |
| Diluted EPS (Net Income) | (0.08) | (0.08) | (0.09) |
Icagen Stock Quote & Chart
08/28/08 14:59:41 EST •
NASDAQ •
1.46
•
 0.0000
•
0.0000 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Icagen Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 3.25 | 3.51 | 1.54 |
| Price/Earnings Ratio | -- | 15.32 | 15.62 |
| Price/Book Ratio | 2.06 | 2.89 | 1.49 |
| Price/Cash Flow Ratio | -- | 12.48 | 9.59 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Icagen Financial Ratios
Icagen Competitive Intelligence
| Abbott Labs | Eli Lilly | Vertex Pharmaceuticals | |
|---|---|---|---|
| Annual Sales ($ mil.) | 25,914.2 | 18,633.5 | 199.0 |
| Employees | 68,000 | 40,600 | 1,150 |
| Market Cap ($ mil.) | 90,149.7 | 54,027.9 | 4,207.3 |
Competitive Landscape
